Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 1.00 |
| ▸ | NPC1 | O15118 | 10/20 | 1.00 |
| ▸ | RAB9A | P51151 | 10/20 | 1.00 |
| ▸ | HPGD | P15428 | 9/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 0.76 |
| ▸ | USP2 | O75604 | 3/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.76 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | POLB | P06746 | 4/20 | 0.69 |
| ▸ | GAA | P10253 | 3/20 | 0.69 |
| ▸ | BLM | P54132 | 2/20 | 0.69 |
| ▸ | PKM | P14618 | 6/20 | 0.68 |
| ▸ | GFER | P55789 | 3/20 | 0.68 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31063849 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL3417301 | 0.88 | NPC1 (0.78) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL9767339 | 0.87 | MEN1 (0.90) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL9767334 | 0.87 | ALDH1A1 (0.77) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL29906364 | 0.87 | ALDH1A1 (0.77) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL29596534 | 0.87 | ALDH1A1 (0.77) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL29377327 | 0.87 | MEN1 (0.90) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL21772077 | 0.86 | ALDH1A1 (1.00) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL6260440 | 0.86 | ALDH1A1 (0.93) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL28027557 | 0.86 | KDM4E (0.75) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115477615-B | N- (3- (benzimidazol-2-yl) phenyl) amide compound and preparation method and application thereof | 黄山学院 | 2024-06-18 | — | — | CN | claimed |
| CN-111808306-B | Polyimide film with low thermal expansion coefficient and preparation method thereof | 浙江中科玖源新材料有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115477615-A | N- (3- (benzimidazole-2-yl) phenyl) amide compound and preparation method and application thereof | 黄山学院 | 2022-12-16 | — | — | CN | claimed |
| CN-111808306-A | Polyimide film with low thermal expansion coefficient and preparation method thereof | 浙江中科玖源新材料有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-122010934-A | Pyrido [1,2-a ] pyrimidine mesoionic derivative containing amide structure, and preparation method and application thereof | 贵州大学 | 2026-05-12 | — | — | CN | disclosed |
| EP-4559908-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | S2CBio Inc. (KR) | 2025-05-28 | — | — | EP | disclosed |
| CN-115477615-B | N- (3- (benzimidazol-2-yl) phenyl) amide compound and preparation method and application thereof | 黄山学院 | 2024-06-18 | — | — | CN | disclosed |
| CN-115477615-B | N- (3- (benzimidazol-2-yl) phenyl) amide compound and preparation method and application thereof | 黄山学院 | 2024-06-18 | — | — | CN | disclosed |
| CN-115477615-B | N- (3- (benzimidazol-2-yl) phenyl) amide compound and preparation method and application thereof | 黄山学院 | 2024-06-18 | — | — | CN | disclosed |
| WO-2024058617-A1 | ANTIVIRAL USE OF HETEROARYL DERIVATIVE COMPOUND | 일동제약(주) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024019541-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | 일동제약(주) | 2024-01-25 | — | — | WO | disclosed |
| WO-2024019541-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | 일동제약(주) | 2024-01-25 | — | — | WO | disclosed |
| WO-2005030206-A1 | ARYL-1,3-AZOLE DERIVATIVES AND METHODS FOR INHIBITING HEPARNASE ACTIVITY | IMCLONE SYSTEMS INCORPORATED (US) | 2005-04-07 | — | — | WO | disclosed |
| EP-1509499-A1 | PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES | GLAXO GROUP LIMITED (GB) | 2005-03-02 | — | — | EP | disclosed |
| US-6858739-B2 | Indole and benzimidazole 15-lipoxygenase inhibitors | WARNER-LAMBERT COMPANY (US) | 2005-02-22 | — | — | US | disclosed |
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | CONNOR DAVID THOMAS (US) | 2004-02-26 | — | — | US | disclosed |
| WO-2003101959-A1 | PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES | GLAXO GROUP LIMITED (GB) | 2003-12-11 | — | — | WO | disclosed |
| EP-1294686-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2003-03-26 | — | — | EP | disclosed |
| WO-2001096299-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| EP-0226016-A1 | Process for inhibiting hydrogen-induced corrosion of metallic materials | BAYER AG (DE) | 1987-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | ALOX15, ALOX5, ALOX12 | ALDH1A1 470/4885KDM4E 881/4885SMN1; SMN2 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.